Cytidine deaminase — Drug Target

2 drugs 2 marketed

All drugs that target Cytidine deaminase — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Nucleoside Metabolic Inhibitor [EPC] · Cytidine deaminase inhibitor

Marketed (2)

Inqovi · Otsuka · Nucleoside Metabolic Inhibitor [EPC] · Oncology
Inqovi works by blocking the enzyme cytidine deaminase, allowing chemotherapy medications to be more effective.
DAC · dr hab. n. med. Agnieszka Wierzbowska · Cytidine deaminase inhibitor · Oncology
DAC is a cytidine deaminase inhibitor that enhances the activity of cytarabine by preventing its inactivation.